{"database": "openregs", "table": "documents", "rows": [["FDA-2022-E-2095-0002", "FDA", "FDA-2022-E-2095", "Patent Extension Application from Merck Sharp & Dohme Corp. (on behalf of Peloton Therapeutics, Inc.)", "Other", "Letter(s)", "2022-08-31T04:00:00Z", 2022, 8, "2022-08-31T04:00:00Z", null, "2022-08-31T20:08:25Z", null, 0, 0, "090000648529e3ba"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2022-E-2095-0002"], "units": {}, "query_ms": 0.5574390524998307, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}